首页|美金刚联合多奈哌齐治疗对阿尔茨海默病患者神经递质及精神行为症状的影响

美金刚联合多奈哌齐治疗对阿尔茨海默病患者神经递质及精神行为症状的影响

扫码查看
目的 探讨美金刚联合多奈哌齐治疗对阿尔茨海默病(AD)患者的影响.方法 选取莘县中心医院 2022 年9月—2023年 10 月收治的 60 例AD患者为研究对象,按照随机数字表法将其分为对照组与观察组,每组 30 例.对照组采用多奈哌齐治疗,观察组在对照组基础上加用盐酸美金刚治疗,两组均持续治疗 12 周.对比两组患者的临床疗效、神经递质、精神行为症状及不良反应发生情况.结果 观察组治疗总有效率为 93.33%,高于对照组的 70.00%,差异有统计学意义(P<0.05).治疗后,观察组 5-羟色胺、多巴胺、乙酰胆碱水平均高于对照组,组间差异有统计学意义(P<0.05);观察组痴呆病理行为评定量表评分为(9.32±1.41)分,低于对照组的(15.29±2.89)分,简易精神状态评定表评分为(22.28±1.18)分,高于对照组的(15.85±1.05)分,组间差异有统计学意义(P<0.05).两组不良反应发生率对比,差异无统计学意义(P>0.05).结论 美金刚联合多奈哌齐治疗AD能够有效调节AD患者的神经递质水平,改善患者的精神行为症状,且用药安全性较高.
Effects of Memantine Combined with Donepezil on Neurotransmitter and Psychological Behavioral Symptoms in Patients with Alzheimer Disease
Objective To investigate the effect of memantine combined with donepezil on patients with Alzheimer disease(AD).Methods Sixty cases of AD patients admitted to Shen County Central Hospital from September 2022 to October 2023 were selected as research objects,and were divided into a control group and an observation group according to random number table method,with 30 cases in each group.The control group was treated with donepezil,and the observation group was treated with memantine hydrochloride on the basis of the control group,both groups were treated for 12 weeks.The clinical efficacy,neurotransmitter,psychological behavioral symptoms and the occurrence of adverse reactions were compared between the two groups.Results The total effective rate of the observation group was 93.33%,which was higher than 70.00%of the control group,and the difference was statistically significant(P<0.05).After treatment,the average levels of 5-hydroxytryptamine,dopamine and acetylcholine in the observation group were higher than those in the control group,and the differences between the groups were statistical significance(P<0.05);the score of the Behavioral Pathology in Alzheimer's Disease rating scale in the observation group was(9.32±1.41)points,which was lower than(15.29±2.89)points in the control group,and the score of the Mini-Mental State Examination rating scale was(22.28±1.18)points,which was higher than(15.85±1.05)points in the control group,and the differences between the groups were statistical significance(P<0.05).There was no significant difference in the incidence of adverse reactions between the two groups(P>0.05).Conclusion Memantine combined with donepezil in the treatment of AD can effectively regulate the level of neurotransmitters in AD patients,improve the psychological behavioral symptoms of patients,and the drug is safe.

Alzheimer diseaseMemantineDonepezilNeurotransmittesPsychological and behavioral symptomsAdverse reactions

郝家新、段翠菲

展开 >

莘县中心医院神经内二科,山东聊城 252400

阿尔茨海默病 美金刚 多奈哌齐 神经递质 精神行为症状 不良反应

2024

反射疗法与康复医学

反射疗法与康复医学

ISSN:
年,卷(期):2024.5(11)